Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2025 ▲▼ | Q1 2026 ▲▼ | Change ▲▼ | Q4 2025 ▲▼ | Q1 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N V COM | 4,639,304 | 4,639,304 | 0 | $128.74M | $131.06M | 46.71% | +$2.32M |
| Alumis Inc | 4,619,803 | 4,528,408 | -91,395 | $45.09M | $99.76M | 35.56% | +$54.67M |
| ALX Oncology Holdings Inc.(ALXO) | 9,699,925 | 12,884,638 | +3,184,713 | $10.96M | $25.83M | 9.21% | +$14.87M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 489,194 | 489,194 | 0 | $18.31M | $13.70M | 4.88% | -$4.60M |
| Lyell Immunopharma, Inc.(LYEL) | 337,697 | 337,697 | 0 | $10.39M | $6.77M | 2.41% | -$3.62M |
| Artiva Biotherapeutics, Inc.(ARTV) | 648,507 | 531,337 | -117,170 | $2.78M | $3.42M | 1.22% | +$639.7K |